Sisram Medical Ltd

What Sisram Medical Ltd does

Sisram Medical Ltd is an Israel-incorporated, Hong Kong-listed (1696.HK) global medical aesthetics and wellness platform majority-owned by Fosun Pharma (复星医药). Founded in 2013 following the acquisition of Alma — a 25-year incumbent in energy-based medical aesthetics devices — Sisram has expanded into a four-brand ecosystem: Alma (energy-based devices spanning laser, radiofrequency, IPL, and ultrasound modalities for hair removal, skin rejuvenation, body contouring, and clinical indications), LMNT (consumer wellness personal-care devices), Copulla (end-to-end digital dentistry workflow built on BEGO CAD-CAM technology), and an injectables portfolio (Profhilo and Aliaxin distributed from IBSA, plus pipeline assets DaxibotulinumtoxinA from Revance and RZL-012 from Raziel Therapeutics).

Sisram operates an enterprise field-sales motion combined with distributor channels across 110+ countries, with direct offices in Israel (Caesarea HQ), China (Shanghai), Japan, and Thailand. Revenue mechanics are anchored in B2B hardware sales of capital equipment and consumables to surgical, medical, and aesthetic clinics, complemented by injectable product distribution, professional-services revenue from Copulla's digital dentistry platform, and a consumer-direct e-commerce line via LMNT. Pricing is not publicly disclosed but follows standard medical-device enterprise sales cycles with clinical training, marketing, and service support.

The company's strategic posture in 2025–2026 emphasizes APAC localization (China manufacturing facility with Sinmait Medical Technology, Thailand expansion), pipeline broadening via AI-personalized skincare (Universkin by Alma) and premium neuromodulators (DAXXIFY), and commercial-led leadership transition. Fosun Pharma remains the controlling shareholder, providing healthcare-distribution synergies and a strategic anchor for the China and APAC buildout.

Name

Sisram Medical Ltd

Legal name

Sisram Medical Ltd

Website

https://sisram-medical.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Sisram Medical Ltd is an HKEX-listed (1696.HK) global medical aesthetics platform operating the Alma energy-based devices brand, injectables portfolio, Copulla digital dentistry service, and LMNT consumer wellness line across 110+ countries, majority-owned by Fosun Pharma.

Ownership category

akta.pro rank

Product category

Medical Aesthetics Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Dental Equipment & Supplies (3843), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices) (CRABAAAJ)

akta.pro secondary industries

Professional Skincare & Facial Treatments (CRABALAF), Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Energy-based aesthetic devices
• Medical aesthetics solutions
• Injectable dermal fillers
• Digital dentistry platform
• Consumer wellness skincare

Headquarters

HQ city

Caesarea

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Energy-Based Devices (EBD) - Alma: Sale of medical aesthetics devices and systems for professional clinic use, including systems for hair removal, skin rejuvenation, body contouring, and other aesthetic treatments. Alma operates as a world-leading provider serving surgical, medical aesthetics and beauty markets.
2. Injectables: Distribution and sale of injectable aesthetic products including Profhilo (bio-remodeling), Aliaxin (dermal fillers), and upcoming products like DaxibotulinumtoxinA (neuromodulator) and RZL-012 (fat dissolving).
3. Consumer Wellness - LMNT: Personal care consumer wellness products including energy-based home use devices for skin rejuvenation and self-care routines.
4. Digital Dentistry - Copulla: Digital dentistry services including CAD-CAM dental technology center, digital workflow solutions, and dental products/services.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Sisram Medical develops, manufactures, and distributes a portfolio of energy-based medical aesthetics devices, injectable aesthetic products, consumer personal-care devices, and a digital dentistry service platform under its Alma, LMNT, Copulla, and Injectables brands. Offerings target professional surgical, medical and beauty clinics worldwide with medical-grade treatments for hair removal, skin rejuvenation, body contouring, acne, pigmentation, feminine health, anti-aging, and dental aesthetics.

Product overview

Sisram Medical Ltd is a global consumer wellness group operating a multi-brand ecosystem focused on medical aesthetics. The company offers four distinct brand lines: Alma (energy-based medical aesthetics devices for clinical treatments), LMNT (consumer personal care/wellness products), Copulla (digital dentistry service platform), and Injectables (dermal fillers, skin boosters, and neuromodulators). Alma serves professional customers with medical-grade treatments for indications including hair removal, skin rejuvenation, body contouring, and feminine health. The company combines energy-based device treatments with injectables therapy for synergistic aging treatment solutions. Sisram was established in 2013 and has been listed on the Hong Kong Stock Exchange since 2017 (1696.HK), with a majority ownership by Fosun Pharma.

Differentiator

Problem solved

Functional benefit

Brands

• Alma: World-leading provider of energy-based solutions for surgical, medical aesthetics and beauty markets. Offers treatments including hair removal, skin rejuvenation, acne treatment, body contouring, facial contouring, and more.
• LMNT
• Copulla
• Injectables

Products and services

• Alma Energy-Based Devices World-leading provider of energy-based medical aesthetics devices for surgical, medical aesthetics and beauty markets, covering hair removal, skin rejuvenation, acne treatment, body/facial contouring, skin resurfacing, feminine health, and related clinical indications. Sold to professional clinics and practitioners globally.
• LMNT Personal Care Personal care brand offering light-based and natural-energy consumer wellness devices for at-home skin rejuvenation and daily self-care routines.
• Copulla Digital Dentistry End-to-end digital dentistry service platform covering intra-oral scanning through CAD-CAM dental appliance production, enabling cost-effective and efficient aesthetic dentistry workflows for dental practitioners.
• Profhilo Injectable Bio-remodeling injectable composed of stabilized hyaluronic acid designed to remodel multi-layer skin tissue, addressing both causes and symptoms of aging.
• Aliaxin Dermal Fillers Non-invasive dermal filler product line containing ultrapure hyaluronic acid for natural contouring, lifting, and hydration across 12 different facial areas.
• Universkin by Alma AI-assisted personalized skincare platform that creates customized skincare formulations based on individual skin analysis using AI algorithms to assess skin characteristics.

Quantifiable outcome

• Serving customers in over 110 countries and regions
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Five partnerships are on record, tiered key, core and emerging.

• Sinmait Medical Technology (星迈泰科医疗科技)keyStrategic or Co-development Partner · 25 January 2026Partnership to build next-generation manufacturing and innovation hub in China, enhancing local production capabilities. First locally produced Alma Rejuve device rolled off the line in June 2026 at the China manufacturing facility.
• IBSAcoreStrategic or Co-development PartnerIBSA is a multinational pharmaceutical corporation and developer of Profhilo (bio-remodeling injectable) and Aliaxin (dermal fillers). IBSA owns 65 exclusive registered patents worldwide. Sisram distributes IBSA's injectable products.
• Revance AestheticskeyStrategic or Co-development PartnerRevance Aesthetics is developing DaxibotulinumtoxinA for Injection (DAXXIFY/达希斐), a premium long-lasting neuromodulator product. Sisram is bringing this product to markets including China, with NIFDC testing completed in January 2026.
• Raziel TherapeuticsemergingStrategic or Co-development PartnerRaziel Therapeutics is a clinical-stage pharmaceutical company developing RZL-012, an injectable treatment for aesthetics indications and fat disorders. A single treatment session results in significant and sustained reduction in fat volume.
• BEGOcoreTechnology or IntegrationBEGO provides dental technology for Copulla's global standard CAD-CAM dental technology center, enabling full suite of dental services and products including digital dentistry workflows.

Scale indicators5 records

Recent moves8 records

Expansion highlights7 records

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Customer concentration

• LinkedInlinkedin.com/company/sisram-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sisram Medical Ltd